2021 Q2 Form 10-Q Financial Statement
#000117494721000508 Filed on May 05, 2021
Income Statement
| Concept | 2021 Q2 | 2020 Q4 | 2020 Q1 |
|---|---|---|---|
| Revenue | $184.4M | $169.3M | $123.6M |
| YoY Change | 41.54% | 61.02% | 8.42% |
| Cost Of Revenue | $111.8M | $105.1M | $87.63M |
| YoY Change | 23.99% | 30.72% | 7.6% |
| Gross Profit | $72.57M | $64.20M | $36.01M |
| YoY Change | 81.03% | 159.06% | 10.47% |
| Gross Profit Margin | 39.36% | 37.92% | 29.12% |
| Selling, General & Admin | $20.61M | $22.10M | $15.85M |
| YoY Change | 28.34% | 49.32% | -1.85% |
| % of Gross Profit | 28.4% | 34.42% | 44.01% |
| Research & Development | |||
| YoY Change | |||
| % of Gross Profit | |||
| Depreciation & Amortization | $7.501M | $6.000M | $7.214M |
| YoY Change | 4.18% | -11.76% | -3.63% |
| % of Gross Profit | 10.34% | 9.35% | 20.03% |
| Operating Expenses | $20.61M | $22.10M | $15.85M |
| YoY Change | 28.34% | 48.32% | -1.85% |
| Operating Profit | $51.96M | $42.10M | $20.16M |
| YoY Change | 116.25% | 326.03% | 22.56% |
| Interest Expense | -$25.00K | $0.00 | -$25.00K |
| YoY Change | -7.41% | -100.0% | -3.85% |
| % of Operating Profit | -0.05% | 0.0% | -0.12% |
| Other Income/Expense, Net | $434.0K | $400.0K | $648.0K |
| YoY Change | -35.51% | 0.0% | -31.65% |
| Pretax Income | $52.39M | $42.60M | $20.81M |
| YoY Change | 112.11% | 294.44% | 19.6% |
| Income Tax | $14.20M | $10.90M | $5.473M |
| % Of Pretax Income | 27.1% | 25.59% | 26.3% |
| Net Earnings | $38.19M | $31.70M | $15.34M |
| YoY Change | 105.4% | 286.21% | 17.69% |
| Net Earnings / Revenue | 20.71% | 18.72% | 12.41% |
| Basic Earnings Per Share | $2.18 | $0.88 | |
| Diluted Earnings Per Share | $2.16 | $1.771M | $0.87 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 17.56M shares | 17.50M shares | 17.46M shares |
| Diluted Shares Outstanding | 17.72M shares | 17.72M shares |
Balance Sheet
| Concept | 2021 Q2 | 2020 Q4 | 2020 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $146.1M | $141.2M | $187.6M |
| YoY Change | -35.53% | -14.37% | 39.07% |
| Cash & Equivalents | $24.14M | $20.15M | $37.98M |
| Short-Term Investments | $122.0M | $121.0M | $149.6M |
| Other Short-Term Assets | $4.200M | $6.300M | $2.900M |
| YoY Change | 61.54% | 80.0% | -6.45% |
| Inventory | $28.75M | $29.08M | $18.29M |
| Prepaid Expenses | |||
| Receivables | $73.20M | $57.88M | $55.80M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $252.2M | $234.4M | $264.6M |
| YoY Change | -14.48% | -5.99% | 16.72% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $70.80M | $70.73M | $73.30M |
| YoY Change | 4.27% | -4.3% | -9.17% |
| Goodwill | $825.0K | ||
| YoY Change | 294.74% | ||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $41.00M | $41.62M | $24.40M |
| YoY Change | 51.85% | 104.65% | 0.41% |
| Total Long-Term Assets | $111.9M | $113.9M | $97.80M |
| YoY Change | 17.87% | 14.29% | -6.86% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $252.2M | $234.4M | $264.6M |
| Total Long-Term Assets | $111.9M | $113.9M | $97.80M |
| Total Assets | $364.1M | $348.3M | $362.4M |
| YoY Change | -6.6% | -0.2% | 9.26% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $34.50M | $12.80M | $28.80M |
| YoY Change | -13.1% | 53.45% | 3.6% |
| Accrued Expenses | $28.30M | $44.00M | $20.70M |
| YoY Change | 6.39% | 115.69% | 10.11% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $73.00M | $81.76M | $62.50M |
| YoY Change | -4.33% | 33.5% | 12.41% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $1.700M | $1.800M | $2.100M |
| YoY Change | -15.0% | -21.74% | -4.55% |
| Total Long-Term Liabilities | $1.700M | $1.800M | $2.100M |
| YoY Change | -15.0% | -21.74% | -4.55% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $73.00M | $81.76M | $62.50M |
| Total Long-Term Liabilities | $1.700M | $1.800M | $2.100M |
| Total Liabilities | $75.60M | $83.60M | $64.60M |
| YoY Change | -3.45% | 31.65% | 11.76% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | $367.8M | $342.6M | |
| YoY Change | -6.95% | ||
| Common Stock | $41.96M | $43.47M | |
| YoY Change | 12.37% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $145.6M | $145.6M | $145.6M |
| YoY Change | 0.0% | ||
| Treasury Stock Shares | 6.710M shares | 6.710M shares | |
| Shareholders Equity | $288.5M | $264.7M | $297.8M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $364.1M | $348.3M | $362.4M |
| YoY Change | -6.61% | -0.2% | 9.26% |
Cashflow Statement
| Concept | 2021 Q2 | 2020 Q4 | 2020 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $38.19M | $31.70M | $15.34M |
| YoY Change | 105.4% | 286.21% | 17.69% |
| Depreciation, Depletion And Amortization | $7.501M | $6.000M | $7.214M |
| YoY Change | 4.18% | -11.76% | -3.63% |
| Cash From Operating Activities | $27.77M | $61.80M | $31.07M |
| YoY Change | -40.91% | 51.84% | -401.6% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $5.516M | -$44.50M | $4.094M |
| YoY Change | -406.44% | 300.9% | 51.01% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$1.000M | -$17.00M | -$20.10M |
| YoY Change | -98.31% | 14.09% | -235.81% |
| Cash From Investing Activities | -$6.495M | -$61.50M | -$24.18M |
| YoY Change | -89.37% | 135.63% | -299.99% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -$17.29M | -9.800M | -$4.331M |
| YoY Change | 174.37% | 415.79% | -11.38% |
| NET CHANGE | |||
| Cash From Operating Activities | $27.77M | 61.80M | $31.07M |
| Cash From Investing Activities | -$6.495M | -61.50M | -$24.18M |
| Cash From Financing Activities | -$17.29M | -9.800M | -$4.331M |
| Net Change In Cash | $3.990M | -9.500M | $2.559M |
| YoY Change | -119.56% | -174.8% | -182.6% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $27.77M | $61.80M | $31.07M |
| Capital Expenditures | $5.516M | -$44.50M | $4.094M |
| Free Cash Flow | $22.25M | $106.3M | $26.98M |
| YoY Change | -54.4% | 105.21% | -307.31% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2021Q2 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
| CY2021Q2 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2021Q2 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
| CY2021Q2 | dei |
Entity Small Business
EntitySmallBusiness
|
false | |
| CY2021Q2 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2021Q2 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2021Q2 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000095029 | |
| CY2021Q2 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | |
| CY2021Q2 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2021Q2 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2021Q2 | us-gaap |
Gross Profit
GrossProfit
|
72566000 | USD |
| CY2021Q2 | us-gaap |
Selling Expense
SellingExpense
|
8088000 | USD |
| CY2021Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
367816000 | USD |
| CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
342615000 | USD |
| CY2021Q2 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
6709898 | shares |
| CY2021Q2 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
145590000 | USD |
| CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
288480000 | USD |
| CY2021Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
364129000 | USD |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
264699000 | USD |
| CY2020Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
USD | |
| CY2021Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
41961000 | USD |
| CY2020Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
145590000 | USD |
| CY2020Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
6709898 | shares |
| CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
348258000 | USD |
| CY2021Q2 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
876000 | USD |
| CY2020Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
43468000 | USD |
| CY2021Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
111811000 | USD |
| CY2020Q1 | us-gaap |
Gross Profit
GrossProfit
|
36009000 | USD |
| CY2020Q1 | us-gaap |
Selling Expense
SellingExpense
|
7636000 | USD |
| CY2021Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
12522000 | USD |
| CY2020Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8210000 | USD |
| CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
38192000 | USD |
| CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
38192000 | USD |
| CY2021Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
20610000 | USD |
| CY2020Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
15846000 | USD |
| CY2021Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
51956000 | USD |
| CY2020Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
20163000 | USD |
| CY2021Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
8000 | USD |
| CY2020Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
566000 | USD |
| CY2021Q2 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-25000 | USD |
| CY2020Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-25000 | USD |
| CY2021Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
451000 | USD |
| CY2020Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
107000 | USD |
| CY2021Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
434000 | USD |
| CY2020Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
648000 | USD |
| CY2021Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
52390000 | USD |
| CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
20811000 | USD |
| CY2021Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
14198000 | USD |
| CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
5473000 | USD |
| CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
38192000 | USD |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
15338000 | USD |
| CY2021Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.18 | |
| CY2020Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.88 | |
| CY2021Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.16 | |
| CY2020Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.87 | |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
17559624 | shares |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
17461524 | shares |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
17718481 | shares |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
17719418 | shares |
| CY2021Q2 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.71 | |
| CY2020Q1 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.18 | |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
264699000 | USD |
| CY2021Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
USD | |
| CY2021Q2 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
|
4801000 | USD |
| CY2021Q2 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
12484000 | USD |
| CY2021Q2 | us-gaap |
Dividends Paidinkind
DividendsPaidinkind
|
507000 | USD |
| CY2021Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3381000 | USD |
| CY2021Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7501000 | USD |
| CY2020Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7214000 | USD |
| CY2021Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3381000 | USD |
| CY2020Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1354000 | USD |
| CY2021Q2 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
11000 | USD |
| CY2020Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
USD | |
| CY2021Q2 | us-gaap |
Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
|
2406000 | USD |
| CY2020Q1 | us-gaap |
Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
|
1530000 | USD |
| CY2021Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
15289000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
3196000 | USD |
| CY2021Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-323000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-10012000 | USD |
| CY2021Q2 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1836000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-266000 | USD |
| CY2021Q2 | rgr |
Contract Liability To Customers
ContractLiabilityToCustomers
|
-84000 | USD |
| CY2020Q1 | rgr |
Contract Liability To Customers
ContractLiabilityToCustomers
|
-1060000 | USD |
| CY2021Q2 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-16495000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
127000 | USD |
| CY2021Q2 | rgr |
Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
|
-108000 | USD |
| CY2020Q1 | rgr |
Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
|
-58000 | USD |
| CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
288480000 | USD |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
15338000 | USD |
| CY2021Q2 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
-530000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
2384000 | USD |
| CY2021Q2 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
9260000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
2460000 | USD |
| CY2021Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
27770000 | USD |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
31071000 | USD |
| CY2021Q2 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
5516000 | USD |
| CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4094000 | USD |
| CY2021Q2 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
11000 | USD |
| CY2020Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
USD | |
| CY2021Q2 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
12484000 | USD |
| CY2021Q2 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
146992000 | USD |
| CY2020Q1 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
89535000 | USD |
| CY2021Q2 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
146002000 | USD |
| CY2020Q1 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
69448000 | USD |
| CY2021Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-6495000 | USD |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-24181000 | USD |
| CY2021Q2 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
4801000 | USD |
| CY2020Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1297000 | USD |
| CY2020Q1 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
3034000 | USD |
| CY2021Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-17285000 | USD |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-4331000 | USD |
| CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
3990000 | USD |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
2559000 | USD |
| CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
20147000 | USD |
| CY2019Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
35420000 | USD |
| CY2021Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
24137000 | USD |
| CY2020Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
37979000 | USD |
| CY2021Q2 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<p id="d1e3237_anchor" style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 1 — BASIS OF PRESENTATION</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:6pt; text-indent:18pt; margin-bottom:0pt; ">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial statements.</p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:6pt; text-indent:18pt; margin-bottom:0pt; ">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the results of the interim periods. Operating results for the three months ended April 3, 2021 may not be indicative of the results to be expected for the full year ending December 31, 2021. These financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. </p> | |
| CY2020Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
84000 | USD |
| CY2019Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
9623000 | USD |
| CY2021Q2 | rgr |
Revenue Deferred
RevenueDeferred
|
USD | |
| CY2020Q1 | rgr |
Revenue Deferred
RevenueDeferred
|
3484000 | USD |
| CY2021Q2 | rgr |
Deferred Revenue Recognized
DeferredRevenueRecognized
|
-84000 | USD |
| CY2020Q1 | rgr |
Deferred Revenue Recognized
DeferredRevenueRecognized
|
-4544000 | USD |
| CY2021Q2 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; margin-bottom:0pt; "> <span style="text-decoration:underline #000000; ">Use of Estimates:</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:6pt; text-indent:18pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. </p> | |
| CY2021Q2 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; margin-bottom:0pt; "> <span style="text-decoration:underline #000000; ">Reclassifications:</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; text-indent:18pt; margin-bottom:0pt; ">Certain prior period balances have been reclassified to conform to current year presentation. </p> | |
| CY2021Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
2905000 | USD |
| CY2020Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
2878000 | USD |
| CY2021Q2 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
77310000 | USD |
| CY2020Q4 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
77609000 | USD |
| CY2021Q2 | us-gaap |
Inventory Gross
InventoryGross
|
80215000 | USD |
| CY2020Q4 | us-gaap |
Inventory Gross
InventoryGross
|
80487000 | USD |
| CY2021Q2 | us-gaap |
Inventory Lifo Reserve
InventoryLIFOReserve
|
48465000 | USD |
| CY2020Q4 | us-gaap |
Inventory Lifo Reserve
InventoryLIFOReserve
|
48016000 | USD |
| CY2021Q2 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
2996000 | USD |
| CY2021Q2 | us-gaap |
Deferred Revenue
DeferredRevenue
|
USD | |
| CY2020Q1 | us-gaap |
Deferred Revenue
DeferredRevenue
|
8563000 | USD |
| CY2020Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
3394000 | USD |
| CY2021Q2 | us-gaap |
Inventory Net
InventoryNet
|
28754000 | USD |
| CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
29077000 | USD |
| CY2021Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1654000 | USD |
| CY2021Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2065000 | USD |
| CY2021Q2 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
419000 | USD |
| CY2021Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
244000 | USD |
| CY2021Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
213000 | USD |
| CY2021Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
215000 | USD |
| CY2021Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
160000 | USD |
| CY2021Q2 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
1440000 | USD |
| CY2021Q2 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
2691000 | USD |
| CY2021Q2 | rgr |
Present Value Discount Of Operating Lease
PresentValueDiscountOfOperatingLease
|
-626000 | USD |
| CY2021Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2065000 | USD |
| CY2021Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P11Y7M9D | |
| CY2021Q2 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
40000000 | USD |
| CY2021Q2 | us-gaap |
Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
|
2021-09-30 | |
| CY2021Q2 | us-gaap |
Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
|
LIBOR | |
| CY2021Q2 | rgr |
Line Of Credit Facility Reference Rate Percentage
LineOfCreditFacilityReferenceRatePercentage
|
0.0011 | pure |
| CY2021Q2 | us-gaap |
Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
|
0.0150 | pure |
| CY2021Q2 | us-gaap |
Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
|
0.0025 | pure |
| CY2020Q1 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
1000000 | USD |
| CY2021Q2 | us-gaap |
Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
|
1300000 | USD |
| CY2020Q1 | us-gaap |
Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
|
900000 | USD |
| CY2021Q2 | rgr |
Estimated Cost For Defined Benefit Plans
EstimatedCostForDefinedBenefitPlans
|
2700000 | USD |
| CY2021Q2 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
2400000 | USD |
| CY2020Q1 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
1500000 | USD |
| CY2021Q2 | rgr |
Defined Benefit Plan Contributions By Employer For Remainder Of Fiscal Year
DefinedBenefitPlanContributionsByEmployerForRemainderOfFiscalYear
|
4000000.0 | USD |
| CY2021Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.271 | pure |
| CY2020Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.263 | pure |
| CY2021Q2 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
200000 | USD |
| CY2020Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1600000 | USD |
| CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
38192000 | USD |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
15338000 | USD |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
17559624 | shares |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
17461524 | shares |
| CY2021Q2 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
158857 | shares |
| CY2020Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
257894 | shares |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
17718481 | shares |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
17719418 | shares |
| CY2021Q2 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | pure |
| CY2021Q2 | us-gaap |
Revenues
Revenues
|
184377000 | USD |
| CY2020Q1 | us-gaap |
Revenues
Revenues
|
123639000 | USD |
| CY2021Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
52390000 | USD |
| CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
20811000 | USD |
| CY2020Q4 | us-gaap |
Assets
Assets
|
348258000 | USD |
| CY2021Q2 | us-gaap |
Assets
Assets
|
364129000 | USD |
| CY2021Q2 | rgr |
Threshold Limit Of Losses Per Transaction For Taking Insurance Coverage On Annual Basis
ThresholdLimitOfLossesPerTransactionForTakingInsuranceCoverageOnAnnualBasis
|
5000000 | USD |
| CY2021Q2 | rgr |
Threshold Limit Of Aggregate Loss For Insurance Coverage On Annual Basis Excluding New Claims From Governments Or Municipalities
ThresholdLimitOfAggregateLossForInsuranceCoverageOnAnnualBasisExcludingNewClaimsFromGovernmentsOrMunicipalities
|
10000000 | USD |
| CY2020 | us-gaap |
Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
|
1100000 | USD |
| CY2019 | us-gaap |
Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
|
100000 | USD |
